Abstract
The antitumor effects of antihypertensive drugs, such as calcium channel blockers, angiotensin I -converting enzyme inhibitors, and angiotensin II type-1 receptor blockers, for patients with advanced pancreatic cancer (APC) has been investigated. However, the real efficacy still remains unclear. According to retrospective studies, hypertensive (HT) patients with APC are significantly older than non-HT patients with APC. There might be major baseline differences in patients‘ characteristics between HT and non-HT patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
